Proteomics analysis revealed that GSTP1 is overexpressed in cisplatin- and irinotecan-resistant glioma [88,89], fluorouracil (5-FU)- and cisplatin-resistant gastric cancer cells [90], doxorubicin-resistant prostate cancer cells [91], and adriamycin-resistant breast cancer cells [92]. The gene discussed is GSTP1; the disease is prostate carcinoma.